市场调查报告书
商品编码
1464867
生物样本采集套件市场:按产品类型、样本类型、应用和最终用户 - 2024-2030 年全球预测Biological Sample Collection Kits Market by Product Type (Blood Collection Kits, Swabs, Viral Transport Media), Sample Type (Blood, Saliva, Stool), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年生物样本采集套件市场规模为86亿美元,预计2024年将达到93.1亿美元,2030年将达到152.9亿美元,复合年增长率为8.57%。
生物样本采集套件是专用的包装,旨在促进各种生物样本的采集、储存和运输,以用于研究、诊断和治疗目的。这些套件包括所有必要的组件,例如拭子、管瓶、试管和储存溶液,以确保样本从采集到分析的完整性和活力。感染疾病的出现和医学研究的持续需求增加了对高效生物样本采集方法的需求。基因组学、蛋白质组学和代谢体学领域不断增加的技术创新需要支持复杂分析的强大样本采集解决方案。有关样本采集、储存和运输的严格规定鼓励采用符合国际标准的标准化采集套件。照护现场和家庭检测解决方案的新兴趋势正在推动对易于使用且可靠的样本采集套件的需求。开发和维护高品质采集套件的成本高昂,尤其是在资源有限的环境中,会影响其普及并阻碍市场成长。样品保存技术和材料的不断改进可提高采集套件的性能和实用性,预计将创造市场成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 86亿美元 |
预测年份 [2024] | 93.1亿美元 |
预测年份 [2030] | 152.9亿美元 |
复合年增长率(%) | 8.57% |
产品类型:扩展采血套件的应用,有效率、安全地采集血液样本
血液采集套件是诊断、医学研究和治疗的重要组成部分。这些套件专为高效、安全地采集、运输和处理血液样本而设计。它通常包括针头、真空容器或註射器、防腐剂、标籤,有时还包括抗凝血剂,以保持血液样本的完整性。其应用范围从基础研究到临床诊断,确保疾病检测、血型检测、生化分析等血液分析结果准确。拭子在从身体各种黏膜表面(例如鼻子、喉咙和泌尿生殖道)收集样本以进行诊断测试方面发挥着重要作用。拭子专门设计用于以最高效率收集生物样本并将其运送到测试平台,而不会影响样本品质。拭子常用于微生物学检测病毒感染、细菌定植或 DNA 检测。拭子类型包括鼻拭子和口腔拭子,每种拭子都是根据特定的样本采集需求量身定制的。病毒运输介质是将病毒、披衣菌感染、霉浆菌和解脲支原体样本从采集点安全运送到实验室的关键产品。 VTM 旨在透过提供受控环境来防止检体因温度变化和污染而劣化,从而保持病毒颗粒的活力。这在感染疾病诊断和研究中尤其重要,因为检体完整性直接影响测试结果的准确性。 VTM根据不同类型测试的特定要求配製,包括缓衝液、蛋白质源、抑制细菌和真菌生长的抗生素以及用于检体保存的冷冻保护剂。
最终用户:诊断中心的血液采集套件在收集各种类型的生物样本方面具有巨大潜力
血库是全球生物样本采集套件市场的重要最终用户。血库依靠这些套件来安全有效地收集、储存和处理血液和血液成分。这些套件有助于确保样本的完整性和纯度,对于输血和其他医疗程序至关重要。对血库的需求是由于血液采集和储存标准化程序的需要以及对捐血及其重要性的认识不断提高而推动的。诊断中心构成生物样本采集套件终端用户市场的重要组成部分。这些中心利用这些套件收集各种类型的生物样本,例如血液、尿液和唾液,用于诊断和疾病监测目的。诊断结果的准确性和可靠性很大程度上取决于样本采集的质量,因此高品质的采集试剂套件至关重要。对早期准确疾病诊断的需求不断增加,增加了诊断中心对这些套件的需求。医院是生物样本采集套件的主要最终使用者。在这种环境下,套件被用于多个部门的众多应用,例如临床测试、研究和治疗监测。这些套件的多功能性和可靠性对于医院为患者提供及时、准确的诊断和治疗至关重要。医院对预防性和个人化医疗的日益重视进一步增加了对先进样本采集解决方案的需求。
区域洞察
由于其强大的医疗基础设施、高额医疗支出以及众多主要企业的存在,美洲是生物样本采集套件的重要市场。受先进研究设施、诊断和个人化医疗投资增加以及疾病诊断意识提高的推动,北美是主要贡献者。此外,加拿大和巴西等国家慢性病盛行率的不断上升以及对医疗保健创新的关注进一步增加了对这些套件的需求。对优质医疗服务的监管支持以及建立的疾病早期检测和监测网络也在市场成长中发挥重要作用。由于医疗基础设施的扩大、医疗成本的上升以及人们对早期诊断重要性的认识不断增强,亚太地区的生物样本采集套件市场正在快速成长。中国和印度等人口众多、感染疾病和非感染疾病疾病盛行率不断上升的国家为市场扩张提供了巨大的机会。该地区政府和私人对医疗保健研发的投资也有所增加,刺激了对采集套件的需求。欧洲-中东-非洲地区的生物样本采集套件市场受到对先进医疗设施、成熟的製药和生物技术研究部门以及德国、英国和法国等国家政府医疗保健政策的高需求的推动,该市场具有丰富的多样性。由于医疗保健基础设施的逐步改善、公众健康意识的提高以及政府(特别是波湾合作理事会(GCC)国家)对医疗保健的投资增加,中东和非洲预计将出现成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估生物采样套件市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生物样本采集套件市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.生物样本采集套件市场的市场规模和预测是多少?
2.在生物样本采集套件市场的预测期间内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.生物样本采集套件市场的技术趋势和法规结构是什么?
4.生物样本采集套件市场主要供应商的市场占有率是多少?
5.进入生物样本采集套件市场合适的型态和策略手段是什么?
[193 Pages Report] The Biological Sample Collection Kits Market size was estimated at USD 8.60 billion in 2023 and expected to reach USD 9.31 billion in 2024, at a CAGR 8.57% to reach USD 15.29 billion by 2030.
Biological sample collection kits are specialized packages designed to facilitate the collection, storage, and transportation of various biological samples for research, diagnostic, and therapeutic purposes. These kits contain all necessary components, such as swabs, vials, tubes, and preservative fluids, ensuring the integrity and viability of the samples from the point of collection to analysis. The emergence of infectious diseases and the ongoing need for medical research amplify the requirement for efficient biological sample collection methods. Growing innovations in genomics, proteomics, and metabolomics necessitate robust sample collection solutions to support complex analyses. The availability of stringent regulations regarding sample collection, storage, and transportation encourages the adoption of standardized collection kits that comply with international standards. The emerging trend toward point-of-care and at-home testing solutions has increased the need for user-friendly and reliable sample collection kits. High development and maintenance of high-quality collection kits are impacting their adoption, especially in resource-limited settings, hampering the growth of the market. Ongoing improvements in sample preservation techniques and materials that enhance the performance and utility of collection kits are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 8.60 billion |
Estimated Year [2024] | USD 9.31 billion |
Forecast Year [2030] | USD 15.29 billion |
CAGR (%) | 8.57% |
Product Type: Growing usage of blood collection kits for the efficient and safe collection of blood samples
Blood collection kits are integral components in diagnostics, medical research, and therapeutic practices. These kits are designed for the efficient and safe collection, transport, and processing of blood samples. They typically include needles, vacutainers or syringes, antiseptics, labels, and sometimes anticoagulants to preserve the integrity of the blood sample. Their usage spans a wide range of applications from basic research to clinical diagnostics, ensuring accurate results in blood analysis for disease detection, blood typing, and biochemical analysis. Swabs play a crucial role in the collection of samples from different mucosal surfaces of the body, such as the nose, throat, and urogenital tract, for diagnostic testing. They are specially designed to collect and transfer biological samples with maximum efficacy to a testing platform without compromising the sample quality. Swabs are commonly used in microbiology for detecting viral infections, bacterial colonization, or for DNA testing. The types of swabs include nasal swabs, oral swabs, and others, each tailored for specific sample collection needs. Viral transport media is a crucial product for the safe transport of viruses, chlamydia, mycoplasma, and ureaplasma samples from the collection site to the testing laboratory. VTM is designed to maintain the viability of the viral particles by providing a controlled environment that prevents specimen deterioration due to temperature changes or contamination. This is particularly important in infectious disease diagnostics and research, where the integrity of the sample directly affects the accuracy of the test results. VTMs are formulated according to the specific requirements of different types of tests and include buffers, protein sources, antibiotics to inhibit bacterial and fungal growth, and cryoprotectants for sample preservation.
End-User: High potential of blood collection kits across diagnostic centers for collecting various types of biological samples
Blood banks are a crucial end-user in the global biological sample collection kits market. They rely on these kits for the safe and efficient collection, storage, and processing of blood and blood components. These kits help ensure the integrity and purity of the samples, which is critical for transfusions and other medical treatments. The demand for blood banks is driven by the need for standardized procedures in blood collection and storage, as well as increasing awareness about blood donation and its importance. Diagnostic centers constitute a significant segment of the end-user market for biological sample collection kits. These centers utilize these kits for collecting various types of biological samples, such as blood, urine, saliva, and others, for the purpose of diagnosis and disease monitoring. The accuracy and reliability of diagnostic results greatly depend on the quality of sample collection, making high-quality collection kits essential. The growing demand for early and accurate disease diagnosis drives the need for these kits in diagnostic centers. Hospitals represent a major end-user group for biological sample collection kits. In this setting, the kits are used across various departments for numerous applications, including clinical testing, research, and treatment monitoring. The versatility and reliability of these kits are vital for hospitals to provide timely and accurate diagnosis and treatment to patients. The increasing emphasis on preventive care and personalized medicine in hospitals further bolsters the demand for advanced sample collection solutions.
Regional Insights
The Americas represents a significant market for biological sample collection kits due to the robust healthcare infrastructure, high healthcare spending, and the presence of a large number of key players in the region. North America is the significant contributor, driven by advanced research facilities, rising investments in diagnostics and personalized medicine, and growing awareness regarding disease diagnosis. Additionally, the increasing prevalence of chronic diseases and the strong focus on healthcare innovation in countries including Canada and Brazil further augment the demand for these kits. Regulatory support for quality healthcare services and an established network for early disease detection and monitoring also play a crucial role in market growth. The Asia-Pacific region is witnessing rapid growth in the biological sample collection kits market, attributed to its expanding healthcare infrastructure, rising healthcare expenditure, and growing awareness regarding the importance of early diagnosis. Countries including China and India, with their large population bases and increasing prevalence of infectious and non-infectious diseases, present significant opportunities for market expansion. The area is also seeing a rise in governmental and private investment in healthcare research and development, adding to the demand for collection kits. The EMEA region's market for biological sample collection kits is diverse due to the high demand for advanced healthcare facilities, a well-established pharmaceutical and biotechnology research sector, and supportive governmental healthcare policies across countries such as Germany, the UK, and France. The Middle East and Africa are expected to grow, driven by the gradual improvement in healthcare infrastructure, increasing awareness about health among the population, and rising investments in healthcare by governments, especially in the Gulf Cooperation Council (GCC) countries.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biological Sample Collection Kits Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biological Sample Collection Kits Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Biological Sample Collection Kits Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Biosigma S.p.A., Cardinal Health, Inc., Eurofins Scientific SE, Exelint International, Co., F. Hoffmann-La Roche Ltd., F.L. Medical S.r.l., Globe Scientific Inc., Greiner AG, Haemonetics Corporation, ICU Medical, Inc., Medtronic PLC, Merck KGaA, Nipro Medical Corporation, Qiagen N.V., Retractable Technologies, Inc., Siemens Healthineers AG, Terumo Corporation, Thermo Fisher Scientific Inc., and Zymo Research Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Biological Sample Collection Kits Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biological Sample Collection Kits Market?
3. What are the technology trends and regulatory frameworks in the Biological Sample Collection Kits Market?
4. What is the market share of the leading vendors in the Biological Sample Collection Kits Market?
5. Which modes and strategic moves are suitable for entering the Biological Sample Collection Kits Market?